# Safety and Tolerability of Escalating Doses of BPN-14967 in Healthy Adults

> **NCT04005807** · PHASE1 · COMPLETED · sponsor: **Belite Bio, Inc** · enrollment: 40 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** BPN-14967
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04005807
- **Lead sponsor:** Belite Bio, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-07-19
- **Primary completion:** 2019-12-20
- **Final completion:** 2019-12-20
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2021-06-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04005807

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04005807, "Safety and Tolerability of Escalating Doses of BPN-14967 in Healthy Adults". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04005807. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*